| Financial Year |
March 31 2023 |
| Monetary Funds |
338,666,172.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
60,663,986.86 |
| Accounts Receivable |
1,512,855,225.44 |
| Advances to Suppliers |
21,845,684.62 |
| Other Receivables |
9,831,926.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
852,022,921.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
152,904,325.05 |
| Total Current Assets |
3,585,448,633.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
188,568,482.74 |
| Investment Properties |
-- |
| Fixed Assetes |
4,597,788,801.27 |
| Under-construction Projects |
1,355,963,812.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
520,805,873.28 |
| R&D expenses |
-- |
| Goodwill |
360,050,623.06 |
| Long-Term Deferred and Prepaid Expenses |
53,636,555.32 |
| Deferred Income Tax Assets |
157,444,995.64 |
| Other Non-Current Assets |
217,453,442.89 |
| Sub-Total of Non-Current Assets |
7,486,556,925.39 |
| Total Assets |
11,072,005,558.87 |
| Short-Term Loans |
901,577,048.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
191,101,773.61 |
| Accounts Payable |
350,888,685.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
95,609,054.27 |
| Taxes Payable |
58,150,834.79 |
| Interest Payable |
-- |
| Dividend Payable |
4,281,450.00 |
| Other payables |
465,507,924.66 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
292,118,752.66 |
| Other Current Liabilities |
16,318,673.20 |
| Sub-Total of Current Liabilities |
2,384,302,400.25 |
| Long-term Loans |
2,246,140,894.55 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
286,281,433.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,692,761,624.57 |
| Total Liabilities |
5,077,064,024.82 |
| Paid-In Capital(Or Share Stock) |
806,318,354.00 |
| Capital Surplus |
2,122,277,580.36 |
| Surplus Reserve |
356,272,183.60 |
| LESS:Treasury Stock |
399,965,257.29 |
| Undistributed Profits |
2,585,056,767.81 |
| Minority Stockholder's Interest |
543,329,095.58 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,451,612,438.47 |
| Owner's Equity（Stockholder's Equity） |
5,994,941,534.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,072,005,558.87 |
